MwanzoDTIL • NASDAQ
add
Precision BioSciences Inc
$ 5.74
Baada ya Saa za Kazi:(1.22%)-0.070
$ 5.67
Imefungwa: 13 Jan, 19:58:07 GMT -5 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 5.70
Bei za siku
$ 5.10 - $ 6.00
Bei za mwaka
$ 3.61 - $ 19.43
Thamani ya kampuni katika soko
45.30M USD
Wastani wa hisa zilizouzwa
elfu 800.37
Uwiano wa bei na mapato
109.54
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 576.00 | -95.61% |
Matumizi ya uendeshaji wa biashara | 21.85M | -14.25% |
Mapato halisi | -16.42M | -103.30% |
Kiwango cha faida halisi | elfu -2.85 | -4,530.66% |
Mapato kwa kila hisa | -2.25 | — |
EBITDA | -20.56M | -91.38% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 101.20M | -17.20% |
Jumla ya mali | 153.26M | -6.75% |
Jumla ya dhima | 88.39M | -34.66% |
Jumla ya hisa | 64.87M | — |
hisa zilizosalia | 7.67M | — |
Uwiano wa bei na thamani | 0.66 | — |
Faida inayotokana na mali | -33.34% | — |
Faida inayotokana mtaji | -53.00% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -16.42M | -103.30% |
Pesa kutokana na shughuli | -5.91M | 74.40% |
Pesa kutokana na uwekezaji | elfu -64.00 | -100.85% |
Pesa kutokana na ufadhili | 3.73M | 11,079.41% |
Mabadiliko halisi ya pesa taslimu | -2.24M | 85.59% |
Mtiririko huru wa pesa | 3.30M | 115.16% |
Kuhusu
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform. Wikipedia
Ilianzishwa
2006
Tovuti
Wafanyakazi
108
